Sanguine Biosciences is pleased to announce the launch of LeukoCert™, GMP-grade leukopaks designed for cell therapy manufacturing. Produced according to strict GMP standards, LeukoCert™ leukopaks are ...

A group of Chinese and Australian researchers offers a novel method for creating CdNCN-CdS heterostructures in mild conditions, advancing solar-driven photocatalysis for hydrogen production.

Breast cancer is the most common malignancy among Western women, with up to 10% of cases attributed to genetic variants.

Getting the best out of a content creator partnership for social search starts with a strong brief.  Without clear, actionable guidelines, even the best creators can miss the mark, leading to ...

Discovery CEO David Zaslav thinks putting Donald Trump back in the White House could offer a friendlier environment for major media mergers. “We have an upcoming new administration,” Zaslav said ...

While this represents a nearly 36% premium to the current stock price of around $11, market skepticism remains about the deal’s final terms and feasibility due to the existing price gap. In contrast ...

Sonrai Analytics (Sonrai), an AI precision medicine company providing advanced analytics to advance therapeutic development, is working to bring its innovative cloud-based AI technology to the Henri & ...

David Zaslav wanted to run Paramount. David Ellison is getting it instead. We now know a lot of the backstory on how that ...

Some observers are bracing for a "gender chasm" between Harris and Trump. Men and women have been voting differently in presidential elections for decades. But could the gender gap be the deciding ...

Great podcasts are all about great chemistry between the hosts—and who has better chemistry than siblings? Here are 10 of the ...

The 2024 presidential contest speeds into its final weekend with Democrat Kamala Harris and Republican Donald Trump locked in ...

Since then, GAP have celebrated more than 50 years of success, launching their iconic blue logo in 1988, creating their sustainability program in 1994, along with joining forces with Next in 2022.